Photronics Reports Third Quarter Fiscal 2017 Results
- Third quarter sales were
$111.6 million , up 3% sequentially with moderate growth in both IC and FPD - Net income attributable to
Photronics, Inc. shareholders was$4.0 million ($0.06 per diluted share) - Increased capital expenditures to fund strategic growth brought net cash1 down slightly during the third quarter to
$277 million ; balance sheet retains financial strength and flexibility to fund growth - Fourth quarter 2017 guidance: sales between
$108 and$116 million ; diluted EPS between$0.03 and$0.09
Third quarter sales were
Net income attributable to
"Third quarter sales improved sequentially as we were able to achieve moderate growth in both IC and FPD," said
Fourth Quarter 2017 Guidance
Kirlin continued, "Our outlook for the fourth quarter calls for performance similar to the third quarter. High-end memory should continue to grow steadily as we've seen every quarter year-to-date. The anticipated recovery in high-end logic has been delayed until 2018. High-end FPD capacity will expand during the quarter, with actual sales growth dependent on the mix of high-end business, which may remain tepid for the quarter. Shifting focus to our balance sheet, our cash balance will likely decrease during the fourth quarter as we ramp up investments for our
Conference Call
A conference call to discuss these results is scheduled for
Non-GAAP Financial Measures
Non-GAAP net income attributable to
- Non-recurring tax benefit in fiscal 2016 related to the recognition of certain tax benefits in
Taiwan that were determined to be realizable in filings for future tax periods - Non-recurring net gain on sale of investment in fiscal 2016
- Interest expense, income tax expense/(benefit), depreciation and amortization, and other items are added to GAAP net income to derive non-GAAP EBITDA
Note:
1. Net cash defined as cash and cash equivalents less long-term borrowings (including current portion), as reported in accordance with GAAP.
About
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements made by or on behalf of
|
|||||||||||||||||||||
Condensed Consolidated Statements of Income | |||||||||||||||||||||
(in thousands, except per share amounts) | |||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||
2017 | 2017 | 2016 | 2017 | 2016 | |||||||||||||||||
Net sales | $ | 111,579 | $ | 108,297 | $ | 123,209 | $ | 329,707 | $ | 376,088 | |||||||||||
Costs and expenses: | |||||||||||||||||||||
Cost of sales | (89,862 | ) | (88,140 | ) | (91,759 | ) | (264,835 | ) | (277,915 | ) | |||||||||||
Gross profit | 21,717 | 20,157 | 31,450 | 64,872 | 98,173 | ||||||||||||||||
Selling, general and administrative | (11,639 | ) | (10,894 | ) | (11,163 | ) | (33,403 | ) | (34,386 | ) | |||||||||||
Research and development | (4,812 | ) | (3,726 | ) | (5,466 | ) | (12,023 | ) | (16,613 | ) | |||||||||||
Operating income | 5,266 | 5,537 | 14,821 | 19,446 | 47,174 | ||||||||||||||||
Gain on sale of investment | - | - | 157 | - | 8,940 | ||||||||||||||||
Other income (expense), net | (134 | ) | (3,622 | ) | 1,237 | (5,839 | ) | (872 | ) | ||||||||||||
Income before income taxes | 5,132 | 1,915 | 16,215 | 13,607 | 55,242 | ||||||||||||||||
Income tax provision | (333 | ) | (431 | ) | (4,762 | ) | (2,814 | ) | (6,136 | ) | |||||||||||
Net income | 4,799 | 1,484 | 11,453 | 10,793 | 49,106 | ||||||||||||||||
Net loss (income) attributable to noncontrolling interests | (798 | ) | 313 | (3,365 | ) | (3,048 | ) | (8,162 | ) | ||||||||||||
Net income attributable to |
$ | 4,001 | $ | 1,797 | $ | 8,088 | $ | 7,745 | $ | 40,944 | |||||||||||
Earnings per share: | |||||||||||||||||||||
Basic | $ | 0.06 | $ | 0.03 | $ | 0.12 | $ | 0.11 | $ | 0.61 | |||||||||||
Diluted | $ | 0.06 | $ | 0.03 | $ | 0.12 | $ | 0.11 | $ | 0.56 | |||||||||||
Weighted-average number of common shares outstanding: | |||||||||||||||||||||
Basic | 68,525 | 68,426 | 67,953 | 68,376 | 67,377 | ||||||||||||||||
Diluted | 69,380 | 69,385 | 74,317 | 69,311 | 76,990 | ||||||||||||||||
|
|||||||
Condensed Consolidated Balance Sheets | |||||||
(in thousands) | |||||||
(Unaudited) | |||||||
|
|
||||||
2017 | 2016 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 340,572 | $ | 314,074 | |||
Accounts receivable | 91,812 | 92,636 | |||||
Inventories | 25,668 | 22,081 | |||||
Other current assets | 10,558 | 12,795 | |||||
Total current assets | 468,610 | 441,586 | |||||
Property, plant and equipment, net | 501,720 | 506,434 | |||||
Intangible assets, net | 18,320 | 19,854 | |||||
Other assets | 19,948 | 20,114 | |||||
Total assets | $ | 1,008,598 | $ | 987,988 | |||
Liabilities and Equity | |||||||
Current liabilities: | |||||||
Current portion of long-term borrowings | $ | 5,541 | $ | 5,428 | |||
Accounts payable and accrued liabilities | 73,769 | 75,889 | |||||
Total current liabilities | 79,310 | 81,317 | |||||
Long-term borrowings | 57,776 | 61,860 | |||||
Other liabilities | 16,384 | 19,337 | |||||
739,282 | 710,363 | ||||||
Noncontrolling interests | 115,846 | 115,111 | |||||
Total equity | 855,128 | 825,474 | |||||
Total liabilities and equity | $ | 1,008,598 | $ | 987,988 | |||
|
|||||||||
Condensed Consolidated Statements of Cash Flows | |||||||||
(in thousands) | |||||||||
(Unaudited) | |||||||||
Nine Months Ended | |||||||||
|
|
||||||||
2017 | 2016 | ||||||||
Cash flows from operating activities: | |||||||||
Net income | $ | 10,793 | $ | 49,106 | |||||
Adjustments to reconcile net income to net cash | |||||||||
provided by operating activities: | |||||||||
Depreciation and amortization | 64,081 | 60,102 | |||||||
Gain on sale of investment | - | (8,940 | ) | ||||||
Changes in assets, liabilities and other | (1,085 | ) | (8,881 | ) | |||||
Net cash provided by operating activities | 73,789 | 91,387 | |||||||
Cash flows from investing activities: | |||||||||
Purchases of property, plant and equipment | (38,759 | ) | (44,828 | ) | |||||
Acquisition of Business | (5,400 | ) | - | ||||||
Proceeds from sale of investments | 167 | 101,853 | |||||||
Other | (458 | ) | 584 | ||||||
Net cash provided by (used in) investing activities | (44,450 | ) | 57,609 | ||||||
Cash flows from financing activities: | |||||||||
Repayments of long-term borrowings | (4,057 | ) | (56,276 | ) | |||||
Proceeds from share-based arrangements | 2,529 | 3,172 | |||||||
Dividends paid to noncontrolling interests | (8,298 | ) | (11,890 | ) | |||||
Other | (33 | ) | (19 | ) | |||||
Net cash used in financing activities | (9,859 | ) | (65,013 | ) | |||||
Effect of exchange rate changes on cash | 7,018 | 1,819 | |||||||
Net increase in cash and cash equivalents | 26,498 | 85,802 | |||||||
Cash and cash equivalents, beginning of period | 314,074 | 205,867 | |||||||
Cash and cash equivalents, end of period | $ | 340,572 | $ | 291,669 | |||||
|
||||||||||||||||
Non-GAAP Financial Measures | ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Financial Information | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
|
|
|
|
|
||||||||||||
2017 | 2017 | 2016 | 2017 | 2016 | ||||||||||||
Reconciliation of GAAP to Non-GAAP Net Income | ||||||||||||||||
Attributable to |
||||||||||||||||
GAAP net income attributable to |
$ | 4,001 | $ | 1,797 | $ | 8,088 | $ | 7,745 | $ | 40,944 | ||||||
Income tax benefit (a) | - | - | - | - | (3,004 | ) | ||||||||||
Gain on sale of investment, net of tax (b) | - | - | - | - | (8,753 | ) | ||||||||||
Non-GAAP net income attributable to |
$ | 4,001 | $ | 1,797 | $ | 8,088 | $ | 7,745 | $ | 29,187 | ||||||
Weighted average number of diluted shares outstanding | ||||||||||||||||
GAAP | 69,380 | 69,385 | 74,317 | 69,311 | 76,990 | |||||||||||
Non-GAAP | 69,380 | 69,385 | 74,317 | 69,311 | 76,990 | |||||||||||
Net income per diluted share | ||||||||||||||||
GAAP | $ | 0.06 | $ | 0.03 | $ | 0.12 | $ | 0.11 | $ | 0.56 | ||||||
Non-GAAP | $ | 0.06 | $ | 0.03 | $ | 0.12 | $ | 0.11 | $ | 0.41 | ||||||
Reconciliation of GAAP Net Income to Non-GAAP EBITDA | ||||||||||||||||
GAAP Net Income (c) | $ | 4,799 | $ | 1,484 | $ | 11,453 | $ | 10,793 | $ | 49,106 | ||||||
Interest expense | 550 | 550 | 612 | 1,658 | 2,750 | |||||||||||
Income tax expense | 333 | 431 | 4,762 | 2,814 | 6,136 | |||||||||||
Depreciation and amortization | 21,840 | 21,345 | 19,572 | 64,081 | 60,102 | |||||||||||
Other items (d) | 984 | 921 | 975 | 2,842 | 2,848 | |||||||||||
Non-GAAP EBITDA | $ | 28,506 | $ | 24,731 | $ | 37,374 | $ | 82,188 | $ | 120,942 | ||||||
Notes:
(a) Represents tax benefit primarily related to the recognition of prior period tax benefits and other tax positions no longer deemed necessary in
(b) Represents gain on sale of investment in a foreign entity
(c) Includes net income attributable to noncontrolling interests, and in 2016 includes gain on sale of investment in a foreign entity
(d) Consists of stock compensation expense
For Further Information:
Director, Investor Relations
(203) 740-5610
tdewar@photronics.com
Source:
News Provided by Acquire Media